Option Care Health, Inc. $OPCH Shares Sold by Trexquant Investment LP

Key Points

• Trexquant Investment LP reduced its stake in Option Care Health by 56.3%, holding 191,490 shares after selling 246,481 shares in the first quarter.
• Directors Timothy P. Sullivan and Harry M. Jansen Kraemer, Jr. significantly increased their ownership by acquiring 20,000 and 36,000 shares, respectively, in August.
• Option Care Health reported a 15.4% year-over-year revenue increase, topping estimates with $1.42 billion in revenue for the last quarter.

Trexquant Investment LP trimmed its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 56.3% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 191,490 shares of the company's stock after selling 246,481 shares during the period. Trexquant Investment LP owned approximately 0.12% of Option Care Health worth $6,693,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the company. Ieq Capital LLC purchased a new stake in shares of Option Care Health in the first quarter valued at approximately $252,000. CreativeOne Wealth LLC boosted its position in shares of Option Care Health by 50.1% during the 1st quarter. CreativeOne Wealth LLC now owns 40,849 shares of the company's stock worth $1,428,000 after purchasing an additional 13,626 shares in the last quarter. GABELLI & Co INVESTMENT ADVISERS INC. purchased a new stake in shares of Option Care Health during the 1st quarter worth $210,000. Teca Partners LP purchased a new position in shares of Option Care Health in the 1st quarter valued at about $13,461,000. Finally, Walleye Trading LLC lifted its stake in shares of Option Care Health by 19.0% in the first quarter. Walleye Trading LLC now owns 30,915 shares of the company's stock valued at $1,080,000 after purchasing an additional 4,946 shares during the period. Hedge funds and other institutional investors own 98.05% of the company's stock.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. JMP Securities upped their target price on shares of Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research report on Thursday, July 31st. Barrington Research reissued an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a report on Thursday, July 10th. Finally, Citigroup reissued an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. Eight analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, Option Care Health currently has a consensus rating of "Moderate Buy" and a consensus target price of $35.75.

Insider Transactions at Option Care Health

In other news, Director Timothy P. Sullivan purchased 20,000 shares of the stock in a transaction on Thursday, August 21st. The stock was purchased at an average price of $27.51 per share, with a total value of $550,200.00. Following the completion of the transaction, the director owned 49,229 shares in the company, valued at approximately $1,354,289.79. The trade was a 68.43% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares of Option Care Health stock in a transaction on Wednesday, August 20th. The shares were bought at an average price of $27.15 per share, for a total transaction of $977,400.00. Following the purchase, the director owned 375,390 shares of the company's stock, valued at $10,191,838.50. This represents a 10.61% increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.64% of the stock is currently owned by insiders.

Option Care Health Trading Up 1.7%

OPCH stock traded up $0.49 during trading on Wednesday, reaching $28.93. 1,900,211 shares of the stock traded hands, compared to its average volume of 1,861,633. The business's 50 day moving average price is $29.47 and its 200-day moving average price is $31.61. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. The firm has a market capitalization of $4.70 billion, a PE ratio of 23.14, a P/E/G ratio of 1.75 and a beta of 0.82.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The firm had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.35 billion. During the same quarter in the previous year, the business earned $0.30 earnings per share. The firm's quarterly revenue was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, sell-side analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.